Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2026

Apr 8, 2026

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

TELIX PHARMACEUTICALS LIMITED

Date of this announcement

Thursday April 09, 2026

The +securities the subject of this notification are:

Unquoted options that have been exercised or other unquoted +convertible securities that have been converted Total number of +securities to be issued/transferred

		Total number of
ASX +security		+securities to be
code	Security description	issued/transferred	Issue date
TLX	ORDINARY FULLY PAID	10,000	23/03/2026

Refer to next page for full details of the announcement

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

1 / 5

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

TELIX PHARMACEUTICALS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type Registration number ACN 616620369

1.3 ASX issuer code

TLX

1.4 The announcement is

New announcement

1.5 Date of this announcement

9/4/2026

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

2 / 5

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

Unquoted options that have been exercised or other unquoted +convertible securities that have been converted

2.2b The +securities being issued, transferred or re-classified as a result of the options being exercised or other +convertible securities being converted are:

securities that have already been quoted on ASX ("existing class")

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

3 / 5

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

==> picture [21 x 22] intentionally omitted <==

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being	The right of the holder of the options or other +convertible securities to receive the +underlying securities is being	The right of the holder of the options or other +convertible securities to receive the +underlying securities is being
satisfied by:
A transfer of existing +securities
The underlying securities being received by the holder are:
Already quoted by ASX
Existing +securities converting into an existing class
FROM (Existing Class)
ASX +Security code and description
TLXAP : SHARE RIGHTS
TO (Existing Class)
ASX +Security code and description
TLX : ORDINARY FULLY PAID
Please state the number of options	The first date the options were	The last date the options were
that were exercised or other	exercised or other +convertible	exercised or other +convertible
+convertible securities that were	securities were converted	securities were converted
converted	13/3/2026	23/3/2026
10,000
Is this all of the options or other +convertible securities on issue of that type?
No
Were the options being exercised or other +convertible securities being converted issued under an +employee
incentive scheme?
Yes
Are any of the options being exercised or other +convertible securities being converted held by +key management
personnel (KMP) or an +associate?
No

Date the +securities the subject of this notification were issued/transferred

23/3/2026

Any other information the entity wishes to provide about the +securities the subject of this notification

10,000 Share Rights have been exercised for no cash consideration, resulting in the transfer of 10,000 ordinary shares. Refer to the Remuneration reports within the 2024 and 2025 Annual Reports accessible at https://ir.telixpharma.com.

Issue details

Number of +securities

10,000

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

4 / 5

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
TLX : ORDINARY FULLY PAID	338,891,048
4.2 Unquoted +securities (Total number of each +class of +securities issued but	not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
TLXAY : DEFERRED SHARE RIGHTS	66,140
TLXAX : DEFERRED SHARE RIGHTS EX-US	60,528
TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL	80,000
TLXAR : PERFORMANCE RIGHTS	9,965,235
TLXAP : SHARE RIGHTS	1,210,004
TLXAO : SHARE APPRECIATION RIGHTS	14,084,553
TLXAT : CONVERTIBLE NOTES	3,250
TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37	208,397
TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL	100,000
TLXAU : DEFERRED SHARE RIGHTS EX-US 2024	10,561
TLXAW : PERFORMANCE SHARE APPRECIATION RIGHTS US 2025	4,319,130
TLXAS : PERFORMANCE SHARE INCENTIVE RIGHTS	440,000

4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities

5 / 5